Sanofi announced that it recently won approval from the European Commission for its NexGard oral flea and tick treatment medication for dogs.

This follows the US FDA’s approval of the medication less than six months ago. The company has already launched NexGard oral in the US.

It plans to launch in Europe soon, followed by other market regions later on.